819 Capital Partners

Linkedin

Vidiia

Vidiia commercialises a fast and accurate molecular diagnostic testing platform with built-in Artificial Intelligence (AI). 

The company is transforming assay development and on-site diagnostics with innovative AI technology. Powered by advanced algorithms and machine learning, the platform of Vidiia revolutionizes the way professionals approach diagnosis.

Vidiia is committed to democratising diagnostic testing with low-cost, portable, AI-powered solutions that can be used anywhere, by anyone.

We invested in Vidiia through 819 Evergreen Fund.

Our news

June 27, 2025

819 Capital makes follow-on investment in ScoutinScience to scale AI-driven research

Deventer, 27 June 2025 – 819 Capital reaffirms its commitment to ScoutinScience by joining their €1 million growth investment round, alongside new angel investors with AI-expertise. The investment will support the further development and international expansion of the company’s AI-powered research valorisation platform. ScoutinScience uses advanced AI and natural language processing to systematically identify, assess, and accelerate the real-world impact of academic research. Its proprietary models uncover untapped innovation potential at scale, enabling universities, TTOs,...

Continue reading
April 17, 2025

819 Capital Partners neemt Finkenflügel Dakbedekkingen B.V. over

Deventer, 17 april 2025 - 819 Capital Partners maakt met trots de strategische samenwerking bekend tussen Finkenflügel Dakbedekkingen B.V. en Crest Construction Group, een platformbedrijf binnen 819 Private Equity Fund I. De acquisitie van Finkenflügel Dakbedekkingen is een strategische stap binnen de buy-and-build strategie van 819 Capital Partners om een toonaangevende groep van gespecialiseerde dakdekkersbedrijven in Nederland te bouwen. Finkenflügel Dakbedekkingen B.V., opgericht in 1987 en gevestigd in Zuid-Holland, heeft een sterke reputatie opgebouwd dankzij...

Continue reading